MCP-Server

phasefolio

com.phasefolio/phasefolio
Finanzen & Investieren Wissenschaft & Engineering Öffentlich und erreichbar MCP 2026-07-28

Was dieses MCP kann

Analyzes biotech drug assets using risk-adjusted valuation, probability-of-success, clinical risk, competitive landscape, evidence, and deal-term data.

get_dossier
Fetch the structured asset snapshot JSON for a scenario — the same content rendered in the PDF/Excel exports, in machine-readable form. Includes verdict, drivers, assumptions, evidence summary, and (if available) signed-export hashes pointing to the latest signed artifacts.
Nur Lesen Externer Zugriff Idempotent
Eingabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['scenario_id'], 'properties': {'scenario_id': {'type': 'string', 'format': 'uuid', 'pattern': '^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$', 'description': 'UUID of the scenario to fetch the asset snapshot payload for.'}}, 'additionalProperties': False}
Ausgabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['data'], 'properties': {'data': {'description': "Structured asset snapshot payload mirroring the PDF/Excel exports. Top-level keys include verdict, drivers, assumptions, evidence, and (when available) signed_export hashes. See get_methodology('evidence-standards') for the full structure."}}, 'description': 'Canonical PhaseFolio envelope. Substantive payload is in `data`.', 'additionalProperties': False}
get_evidence
Fetch the evidence register entries for a scenario — the citations, sources, and supporting documents the analyst attached to back the assumptions. Use this when an analysis question references 'what's the evidence for X?'
Nur Lesen Externer Zugriff Idempotent
Eingabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['scenario_id'], 'properties': {'scenario_id': {'type': 'string', 'format': 'uuid', 'pattern': '^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$', 'description': 'UUID of the scenario whose evidence register entries to fetch.'}}, 'additionalProperties': False}
Ausgabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['data'], 'properties': {'data': {'type': 'array', 'items': {}, 'description': 'Array of evidence-register entries. Each entry has fields like assumption_path, source_url, source_date, excerpt, freshness, confidence — see /methodology/evidence-standards for the canonical schema.'}}, 'description': 'Canonical PhaseFolio envelope. Substantive payload is in `data`.', 'additionalProperties': False}
get_methodology
Fetch a PhaseFolio methodology section's full content (rNPV model, backtest, PoS calibration, IRA framework, development paths, deal-term modelling, holding valuation, clinical stage normalization, evidence standards, network benchmarks, COGS benchmark, SG&A benchmark, tax benchmark, SEC EDGAR deal-term extraction). Designed for citation: each section has a stable URL and a methodology version identifier you can reference in analysis output.
Nur Lesen Externer Zugriff Idempotent
Eingabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['section'], 'properties': {'section': {'enum': ['rnpv', 'backtest', 'pos-calibration', 'ira-framework', 'development-paths', 'deal-term-modelling', 'holding-valuation', 'stage-normalization', 'evidence-standards', 'network-benchmarks', 'cogs-benchmark', 'sga-benchmark', 'tax-benchmark', 'sec-deal-terms'], 'type': 'string', 'description': "Which methodology section to fetch. 'rnpv' covers the core risk-adjusted NPV calculation: cumulative PoS, midpoint-discounted risk-adjusted development costs, the S-curve ramp/plateau/LOE revenue lifecycle net of COGS/SG&A/tax, WACC discounting, the rNPV and Unadjusted-NPV equations, Monte Carlo / expected NPV, and one-at-a-time sensitivity; 'backtest' covers the validation methodology and AUC/CI numbers; 'pos-calibration' covers the indication × modality × biomarker matrix, expanded modality normalization into the eight benchmark baselines, the scored multipliers including the model 2.6.0 biomarker_quality drug-specific multiplier (oncology solid tumor, Phase II/III), the Phase 1 ORR extracted-but-not-scored signal with its Phase 0 governance disclosure, and the non-scored drug-specific risk flags; 'ira-framework' covers the Year-9/Year-13 MFP cliff modeling and the separate IRA classification for expanded modalities such as RNA Therapeutics, Protein Degrader, Radioligand, Oncolytic Virus, and Cancer Vaccine; 'development-paths' covers development-path tiers, automatic-effect policy, and the no path-based PoS/default-multiplier rule; 'deal-term-modelling' covers how licensing deal terms map onto a scenario's deal structure (term-model mapping v1): what is modelled, not modelled and refused, the territory restriction and the approximations it names, milestone timing at stage ends, the cost-share rule, and the non-USD conversion-rate refusal; 'holding-valuation' covers how a Workspace holding is valued (scenario, share of asset value, look-through estimate, cost, not valued): each method's inputs, reason codes and completeness, the totals rules (never added across bases or currencies, estimates left out by default) and what the look-through estimate ignores; 'stage-normalization' covers exact clinical labels, work packages, canonical PoS gates, and the no label-only PoS modifier rule for Phase 1b/2a/2b, adaptive, pivotal, expansion, platform, bridging, and related labels; 'evidence-standards' covers source tiers and freshness rules; 'network-benchmarks' covers anonymization and cohort cuts; 'cogs-benchmark' covers the per-modality COGS% default bands and price-sensitivity methodology; 'sga-benchmark' covers the per-commercial-model SG&A% default bands (orphan/specialty/primary-care); 'tax-benchmark' covers the US-statutory-21% default tax rate, effective-rate reality, and the NOL cap; 'sec-deal-terms' is the retirement notice for the SEC EDGAR deal-term source (retired 2026-09-27), with its frozen versions."}}, 'additionalProperties': False}
Ausgabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['data'], 'properties': {'data': {'type': 'object', 'required': ['section_id', 'title', 'version', 'citation_url', 'summary'], 'properties': {'title': {'type': 'string'}, 'summary': {'type': 'string', 'description': 'Short summary suitable for inline quoting (≤500 chars).'}, 'version': {'type': 'string', 'description': "Versioned identifier for this section's content, e.g. 'methodology@2026-04'."}, 'section_id': {'enum': ['rnpv', 'backtest', 'pos-calibration', 'ira-framework', 'development-paths', 'deal-term-modelling', 'holding-valuation', 'evidence-standards', 'network-benchmarks', 'cogs-benchmark', 'sga-benchmark', 'tax-benchmark', 'sec-deal-terms'], 'type': 'string', 'description': 'Stable section identifier — reuse as the citation key.'}, 'citation_url': {'type': 'string', 'description': 'Public canonical URL — cite this in analysis output.'}, 'last_updated': {'type': 'string', 'description': 'ISO 8601 date of the last meaningful edit.'}}, 'additionalProperties': {}}}, 'description': 'Canonical PhaseFolio envelope. Substantive payload is in `data`.', 'additionalProperties': False}
get_project
Fetch a PhaseFolio project's metadata: indication, sub-indication, modality, biomarker, asset name, and stage at entry. Use this when you need to ground an analysis question in the project's clinical context before fetching scenarios.
Nur Lesen Externer Zugriff Idempotent
Eingabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['project_id'], 'properties': {'project_id': {'type': 'string', 'format': 'uuid', 'pattern': '^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$', 'description': 'UUID of the PhaseFolio project. Get from the project URL in the dashboard or from a prior list_scenarios call.'}}, 'additionalProperties': False}
Ausgabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['data'], 'properties': {'data': {'type': 'object', 'required': ['id', 'name', 'indication', 'modality', 'current_stage', 'created_at', 'updated_at'], 'properties': {'id': {'type': 'string', 'format': 'uuid', 'pattern': '^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$', 'description': 'Stable PhaseFolio project UUID.'}, 'name': {'type': 'string', 'description': 'Display name of the project.'}, 'modality': {'anyOf': [{'type': 'string'}, {'type': 'null'}], 'description': "Modality, e.g. 'Antibody', 'Small Molecule'. Null for unset."}, 'created_at': {'type': 'string', 'description': 'ISO 8601 timestamp of project creation.'}, 'indication': {'anyOf': [{'type': 'string'}, {'type': 'null'}], 'description': "Indication, e.g. 'NSCLC' or 'Rheumatoid Arthritis'. Null for unset."}, 'updated_at': {'type': 'string', 'description': 'ISO 8601 timestamp of last project metadata update.'}, 'current_stage': {'anyOf': [{'type': 'string'}, {'type': 'null'}], 'description': "Current development stage, e.g. 'Phase 2'. Null for unset."}}, 'additionalProperties': False}}, 'description': 'Canonical PhaseFolio envelope. Substantive payload is in `data`.', 'additionalProperties': False}
get_scenario
Fetch a PhaseFolio scenario's complete inputs (stage costs, durations, PoS, commercial assumptions, IRA settings) and computed outputs (eNPV, rNPV, cumulative PoS, per-stage breakdown, top sensitivity drivers). This is the authoritative model output — every signed export ties back to this payload.
Nur Lesen Externer Zugriff Idempotent
Eingabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['scenario_id'], 'properties': {'scenario_id': {'type': 'string', 'format': 'uuid', 'pattern': '^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$', 'description': 'UUID of the scenario. Get from list_scenarios or the scenario URL in the dashboard.'}}, 'additionalProperties': False}
Ausgabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['data'], 'properties': {'data': {'type': 'object', 'required': ['id', 'label', 'project_id', 'is_base', 'created_at', 'updated_at', 'inputs', 'result', 'model_version', 'modality', 'mfp_discount'], 'properties': {'id': {'type': 'string', 'format': 'uuid', 'pattern': '^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$', 'description': 'Scenario UUID. Pass to get_scenario, get_evidence, or get_dossier.'}, 'label': {'type': 'string', 'description': "Human-friendly scenario name, e.g. 'Base Case' or 'Bear Case'."}, 'inputs': {'description': 'Full scenario inputs blob (stages, costs, durations, PoS, commercial assumptions, IRA settings). Schema mirrors the wizard input model.'}, 'result': {'description': 'Full model output blob: eNPV (USD M), rNPV (USD M), cumulative_pos, per_stage_breakdown[], top sensitivity drivers, optional Monte Carlo percentiles.'}, 'is_base': {'type': 'boolean', 'description': 'True if this is the base case scenario for the project.'}, 'modality': {'anyOf': [{'type': 'string'}, {'type': 'null'}], 'description': 'Modality from inputs_json (echoed for convenience).'}, 'created_at': {'type': 'string', 'description': 'ISO 8601 timestamp.'}, 'project_id': {'type': 'string', 'format': 'uuid', 'pattern': '^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$', 'description': 'UUID of the parent project.'}, 'updated_at': {'type': 'string', 'description': 'ISO 8601 timestamp of last scenario edit.'}, 'mfp_discount': {'anyOf': [{'type': 'number'}, {'type': 'null'}], 'description': 'IRA Maximum Fair Price discount magnitude (0–1) used in this scenario, if applicable.'}, 'model_version': {'anyOf': [{'type': 'string'}, {'type': 'null'}], 'description': "Model version that produced `result` (the result's own engine_version key). Null when the scenario has not been computed."}}, 'additionalProperties': False}}, 'description': 'Canonical PhaseFolio envelope. Substantive payload is in `data`.', 'additionalProperties': False}
list_scenarios
List all scenarios in a PhaseFolio project. Returns scenario IDs, names, created/updated timestamps, and top-line eNPV/rNPV. Use this to discover what scenarios exist before fetching one in detail.
Nur Lesen Externer Zugriff Idempotent
Eingabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['project_id', 'limit'], 'properties': {'limit': {'type': 'integer', 'default': 50, 'maximum': 200, 'minimum': 1, 'description': 'Maximum number of scenarios to return (1–200). Defaults to 50; raise for projects with many what-if branches.'}, 'project_id': {'type': 'string', 'format': 'uuid', 'pattern': '^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$', 'description': 'UUID of the parent project whose scenarios to list.'}}, 'additionalProperties': False}
Ausgabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['data'], 'properties': {'data': {'type': 'array', 'items': {'type': 'object', 'required': ['id', 'label', 'project_id', 'is_base', 'created_at', 'updated_at'], 'properties': {'id': {'type': 'string', 'format': 'uuid', 'pattern': '^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$', 'description': 'Scenario UUID. Pass to get_scenario, get_evidence, or get_dossier.'}, 'label': {'type': 'string', 'description': "Human-friendly scenario name, e.g. 'Base Case' or 'Bear Case'."}, 'is_base': {'type': 'boolean', 'description': 'True if this is the base case scenario for the project.'}, 'created_at': {'type': 'string', 'description': 'ISO 8601 timestamp.'}, 'project_id': {'type': 'string', 'format': 'uuid', 'pattern': '^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$', 'description': 'UUID of the parent project.'}, 'updated_at': {'type': 'string', 'description': 'ISO 8601 timestamp of last scenario edit.'}}, 'additionalProperties': False}, 'description': 'Scenarios in the project, newest first.'}}, 'description': 'Canonical PhaseFolio envelope. Substantive payload is in `data`.', 'additionalProperties': False}
query_benchmarks
Query PhaseFolio benchmark availability. Source-backed PoS benchmarks are available separately; network cost distributions and duration percentiles are planned but currently return coming_soon with null estimates rather than PhaseFolio's manual planning defaults.
Nur Lesen Externer Zugriff Idempotent
Eingabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['indication', 'metric'], 'properties': {'metric': {'enum': ['pos', 'cost', 'duration', 'all'], 'type': 'string', 'description': 'Which benchmark family to request. Cost and duration network benchmarks are currently coming_soon and return no estimate; manual wizard defaults are not returned as benchmarks.'}, 'modality': {'type': 'string', 'description': "Optional modality filter ('Antibody', 'Small Molecule', 'Cell Therapy', 'Gene Therapy', etc.). Omit to return cross-modality stats."}, 'indication': {'type': 'string', 'description': "Indication name (e.g. 'NSCLC', 'Rheumatoid Arthritis', 'Atopic Dermatitis'). Free-form; the model fuzz-matches to the canonical indication taxonomy."}}, 'additionalProperties': False}
Ausgabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['data'], 'properties': {'data': {'type': 'object', 'required': ['version', 'available_metrics', 'planning_defaults_excluded', 'note', 'methodology_url'], 'properties': {'note': {'type': 'string', 'description': 'Plain-language benchmark-availability and provenance note.'}, 'version': {'type': 'string', 'description': "Stable version identifier of this benchmark snapshot, e.g. 'preview-2026-04'."}, 'headlines': {'type': 'array', 'items': {'type': 'object', 'required': ['metric', 'value', 'n', 'status'], 'properties': {'n': {'anyOf': [{'type': 'number'}, {'type': 'null'}], 'description': "Sample size behind the value; null when status='coming_soon'."}, 'value': {'anyOf': [{'type': 'number'}, {'type': 'null'}], 'description': "Numeric value; null when status='coming_soon'."}, 'metric': {'type': 'string', 'description': "Metric name, e.g. 'Phase II RA trial cost (median, USD M)'."}, 'status': {'type': 'string', 'description': "Status, e.g. 'live' or 'coming_soon'."}}, 'additionalProperties': False}, 'description': 'Headline aggregates returned at the public tier.'}, 'coming_soon': {'type': 'string', 'description': "Set when this metric family hasn't published yet; explains when it will."}, 'methodology_url': {'type': 'string', 'description': 'Path to the methodology section that explains how these were computed.'}, 'available_metrics': {'type': 'array', 'items': {'type': 'string'}, 'description': 'Network benchmark metric families with published numeric estimates.'}, 'planning_defaults_excluded': {'type': 'boolean', 'description': 'True when manual PhaseFolio planning defaults are intentionally excluded.'}}, 'description': 'L1 (no-auth) returns a versioned headline set; L3 (bearer) will return granular slices once enough orgs are on the network.', 'additionalProperties': False}}, 'description': 'Canonical PhaseFolio envelope. Substantive payload is in `data`.', 'additionalProperties': False}
query_drug_risk
Fetch human-reviewed drug-specific clinical-risk signals for a project, including biomarker quality, Phase 1 ORR flag-only data, provenance, extractor versions, and pending-review counts. Use this before interpreting model 2.6.0 drug-specific multipliers or flags.
Nur Lesen Externer Zugriff Idempotent
Eingabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['project_id'], 'properties': {'project_id': {'type': 'string', 'format': 'uuid', 'pattern': '^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$', 'description': 'UUID of the project whose reviewed drug-specific clinical-risk signals should be queried.'}}, 'additionalProperties': False}
Ausgabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['data'], 'properties': {'data': {'type': 'object', 'required': ['project_id', 'drug_name', 'indication', 'modality', 'reviewed_count', 'pending_count', 'scoring_gate', 'scoring_review_decisions', 'phase1_orr_treatment', 'signals', 'extractor_versions'], 'properties': {'signals': {'type': 'array', 'items': {}, 'description': 'Reviewed signal rows with provenance, extracted values, review state, and OR metadata.'}, 'modality': {'anyOf': [{'type': 'string'}, {'type': 'null'}], 'description': 'Project modality, if set.'}, 'drug_name': {'type': 'string', 'description': 'Project asset name used to match reviewed drug-specific signal rows.'}, 'indication': {'anyOf': [{'type': 'string'}, {'type': 'null'}], 'description': 'Project indication, if set.'}, 'project_id': {'type': 'string', 'format': 'uuid', 'pattern': '^([0-9a-fA-F]{8}-[0-9a-fA-F]{4}-[1-8][0-9a-fA-F]{3}-[89abAB][0-9a-fA-F]{3}-[0-9a-fA-F]{12}|00000000-0000-0000-0000-000000000000|ffffffff-ffff-ffff-ffff-ffffffffffff)$', 'description': 'Project UUID used to anchor the lookup.'}, 'scoring_gate': {'type': 'string', 'const': 'reviewed_at_not_null', 'description': 'Human-review gate required before a signal can score.'}, 'pending_count': {'type': 'integer', 'maximum': 9007199254740991, 'minimum': -9007199254740991, 'description': 'Number of matching signal rows still waiting for human review.'}, 'reviewed_count': {'type': 'integer', 'maximum': 9007199254740991, 'minimum': -9007199254740991, 'description': 'Number of reviewed approved/amended signals returned.'}, 'extractor_versions': {'type': 'array', 'items': {}, 'description': 'Recent extractor prompt versions that produced this signal family.'}, 'phase1_orr_treatment': {'type': 'string', 'const': 'flag_only_engine_2_6_0', 'description': 'Phase 1 ORR is surfaced but not scored in model 2.6.0.'}, 'scoring_review_decisions': {'type': 'array', 'items': {'type': 'string'}, 'description': 'Review decisions eligible for scoring or surfacing.'}}, 'description': 'Drug-specific clinical-risk substrate for a project. Returns reviewed signals only; pending rows are counted but excluded from scoring.', 'additionalProperties': False}}, 'description': 'Canonical PhaseFolio envelope. Substantive payload is in `data`.', 'additionalProperties': False}
triage_asset
Produce a transparent, provenance-linked CONDITIONAL READ on a drug asset for deal triage. Pass either `text` (a teaser/abstract — fields are machine-extracted and the result is marked inputs_unconfirmed) or pre-confirmed `fields`. Returns a reasoning chain (each claim grounded or marked insufficient_evidence), mechanism-plausibility flags, PoS metrics, and a meta block with model/methodology/synthesis versions. Does NOT compute rNPV. Not an autonomous verdict.
Nur Lesen Externer Zugriff Idempotent
Eingabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'properties': {'text': {'type': 'string', 'description': 'Unstructured asset text; triggers extraction (inputs_unconfirmed=true).'}, 'fields': {'type': 'object', 'required': ['modality', 'target', 'indication', 'stage', 'comparators', 'biomarker_strategy'], 'properties': {'stage': {'type': 'string'}, 'target': {'type': 'string'}, 'modality': {'type': 'string'}, 'indication': {'type': 'string'}, 'comparators': {'type': 'array', 'items': {'type': 'string'}, 'default': []}, 'biomarker_strategy': {'type': 'string', 'default': 'none'}}, 'description': 'Pre-confirmed structured fields.', 'additionalProperties': False}}, 'additionalProperties': False}
Ausgabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['data'], 'properties': {'data': {}}, 'description': 'Canonical PhaseFolio envelope. Substantive payload is in `data`.', 'additionalProperties': False}
verify_export
Verify a signed PhaseFolio export by content hash. Returns verification status (valid/tampered/unknown), issued timestamp, methodology version, and an anonymized originating-org identifier. Use this when a user shares a PhaseFolio asset snapshot and you want to confirm it's authentic before citing the analysis.
Nur Lesen Externer Zugriff Idempotent
Eingabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['hash'], 'properties': {'hash': {'type': 'string', 'pattern': '^[a-f0-9]{64}$', 'description': "64-character hex SHA-256 of the signed artifact's content. Embedded in every signed PhaseFolio PDF (footer) and Excel (cover tab)."}}, 'additionalProperties': False}
Ausgabeschema
{'type': 'object', '$schema': 'https://json-schema.org/draft/2020-12/schema', 'required': ['data'], 'properties': {'data': {'oneOf': [{'type': 'object', 'required': ['status', 'content_hash', 'signed_at', 'methodology_version', 'model_version', 'engine_version', 'benchmark_dataset_versions', 'signals_used', 'format', 'org', 'indication', 'modality', 'evidence_count'], 'properties': {'org': {'type': 'string', 'description': 'Anonymized originating-org identifier, or display name if the org opted into public attribution.'}, 'format': {'type': 'string', 'description': "Export format: 'pdf' or 'xlsx'."}, 'status': {'type': 'string', 'const': 'valid'}, 'modality': {'anyOf': [{'type': 'string'}, {'type': 'null'}]}, 'signed_at': {'type': 'string', 'description': 'ISO 8601 timestamp the artifact was signed at.'}, 'indication': {'anyOf': [{'type': 'string'}, {'type': 'null'}]}, 'content_hash': {'type': 'string'}, 'signals_used': {'description': 'Reviewed drug-specific signal provenance included in the signed content hash; [] for none or legacy rows.'}, 'model_version': {'type': 'string', 'description': "Model version stamp at signing time. Sentinel 'unknown (pre-2026-05)' for legacy rows."}, 'engine_version': {'type': 'string', 'description': 'Deprecated alias of model_version, kept for existing clients.'}, 'evidence_count': {'anyOf': [{'type': 'number'}, {'type': 'null'}]}, 'methodology_version': {'type': 'string', 'description': "Methodology version stamp at signing time, e.g. 'methodology@2026-04'."}, 'benchmark_dataset_versions': {'description': "Array of benchmark dataset versions used; '[]' for legacy rows."}}, 'additionalProperties': False}, {'type': 'object', 'required': ['status', 'message'], 'properties': {'status': {'type': 'string', 'const': 'unknown'}, 'message': {'type': 'string'}}, 'additionalProperties': False}]}}, 'description': 'Canonical PhaseFolio envelope. Substantive payload is in `data`.', 'additionalProperties': False}
Entfernt
query_sec_deal_terms
29. September 2026 03:02
Entfernt
query_landscape
29. September 2026 03:02
Entfernt
query_evidence_atlas
29. September 2026 03:02
Geändert
get_methodology
29. September 2026 03:02
Geändert
triage_asset
29. September 2026 03:02
Geändert
verify_export
29. September 2026 03:02
Geändert
query_benchmarks
29. September 2026 03:02
Geändert
query_drug_risk
29. September 2026 03:02
Geändert
get_scenario
29. September 2026 03:02
Hinzugefügt
get_methodology
17. September 2026 12:36
Hinzugefügt
triage_asset
17. September 2026 12:36
Hinzugefügt
query_sec_deal_terms
17. September 2026 12:36
Hinzugefügt
verify_export
17. September 2026 12:36
Hinzugefügt
query_benchmarks
17. September 2026 12:36
Hinzugefügt
query_drug_risk
17. September 2026 12:36
Hinzugefügt
query_evidence_atlas
17. September 2026 12:36
Hinzugefügt
query_landscape
17. September 2026 12:36
Hinzugefügt
get_dossier
17. September 2026 12:36
Hinzugefügt
get_evidence
17. September 2026 12:36
Hinzugefügt
get_scenario
17. September 2026 12:36
Hinzugefügt
list_scenarios
17. September 2026 12:36
Hinzugefügt
get_project
17. September 2026 12:36

Kirk — Unsupervised Structural Change Detection

io.github.UlyssesModel/kirk-mcp

Scores financial order-book snapshots and sequences for structural change and entropy using sealed statistical models.

NatGasLens — US Natural Gas & Henry Hub Data

com.natgaslens/natgaslens

Delivers US natural-gas and Henry Hub market analysis covering LNG feedgas, outages, storage, weather, production, forward curves…

PJM vs MISO Energy Arbitrage Oracle

io.github.dornansgar390-hue/energy-oracle

Delivers subscription-gated PJM and MISO wholesale electricity arbitrage signals, profitability checks, and on-chain subscription…

MaCalculatriceEnLigne

io.github.tresor4k/macalc-mcp

Provides calculators for French and Belgian taxes, salaries, pensions, VAT, loans, health metrics, education scores, fitness, and…

Lovie Company Formation

co.lovie/company-formation

Supports company formation and business administration with bank accounts, cards, invoicing, bookkeeping, accounting periods, and…

AlpineDataWorks Intelligence Server

com.alpinedataworks/adw-intelligence-server

Provides economic, market, supply-chain, real-estate, energy, consumer, labor, and other scored intelligence indices with histori…

The Stall

ai.intuitek.the-stall/the-stall

Provides pay-per-call tools for YouTube keyword research and research on stocks, crypto, DeFi, options, and macroeconomic data.

Stratalize Finance

com.stratalize/finance

Provides financial, macroeconomic, banking, credit, commodities, M&A, ESG, labor, and regulatory benchmarks for analysis and plan…